Virginia (202) 466-6937

PRESS RELEASE: Youngevity, Inc. Supports FDA Proposed Rule That Would Mandate Selenium in Infant Formula

On June 19, 2013, Emord & Associates, on behalf of Youngevity, Inc., filed a Comment to FDA’s proposed rule, “Infant Formula: The Addition of Minimum and Maximum Levels of Selenium to Infant Formula and Related Labeling Requirements.”  If adopted, the Rule would require inclusion of selenium as an essential nutrient in infant formula. FDA concluded […]

FDA Takes Broad Aim at Caffeine

In the midst of supposed cinching of financial waist belts and hard budget choices, the FDA announced this past week that it would begin investigating the “trend” in foods that are being manufactured to include caffeine.  The announcement was thereafter memorialized on the FDA’s website.  This news arrives in the advent of Mars, Inc. announcing […]

Sequestration Effects

By Lou Caputo On February 8, 2013, the White House Office of the Press Secretary released a Fact Sheet memorandum entitled “Examples of How the Sequester Would Impact Middle Class Families, Jobs and Economic Security.”  The memo offered hypothetical examples of how the automatic budget cuts, known as “sequestration,” could affect various federal agencies, such […]

Combination OTC Drug/Supplement Products

By Lou Caputo The FDA recently issued its Final Rule concerning good manufacturing practice requirements for combination products.  For those engaged in the dietary supplement industry and familiar with combination products, it comes as no surprise that there is no mention of dietary supplements in the Final Rule.  The Rule stands as another reminder, however, […]

FDA’s Budget in Limbo

By Lou Caputo Among the so-called winners and losers of Congress’ American Taxpayer Relief Act of 2012 (ATRA), otherwise referred to as the “Fiscal Cliff Bill,” the FDA and other agencies narrowly escaped having their federal allowance trimmed.  This comes as welcome news to the agency; however, those who consider the FDA budget currently bloated […]

Whether evaluating a concept, performing regulatory due diligence, maintaining or prosecuting regulatory filings, or contesting adverse litigation, Emord & Associates provides exceptional counsel for all your litigation and regulatory needs.

Virginia (Firm HQ)

11808 Wolf Run Lane
Clifton, VA 20124
Telephone: (202) 466-6937
Telecopier: (202) 466-6938